rivogenlecleucel: Clinical Trials

5 trials of rivogenlecleucel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 active not recruiting. 5 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 3, Active not recruiting 2
Phase 14Active not recruiting 2, Terminated 2
Phase 31Terminated 1

Follow rivogenlecleucel: new trials by email Literature Review of rivogenlecleucel trials Research Report on rivogenlecleucel

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
rivogenlecleucel, rimiducid, Cyclophosphamide - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 2 / Phase 3TerminatedBellicum Pharmaceuticals12018-12-272023-09-29
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Rimiducid, rivogenlecleucel - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child
Phase 1 / Phase 2TerminatedBellicum Pharmaceuticals1872017-01-012023-09-26
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child
Phase 1 / Phase 2Active not recruitingBellicum Pharmaceuticals1202014-04-012022-07-12
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child
Phase 1 / Phase 2TerminatedBellicum Pharmaceuticals1872014-04-012023-09-29
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
BPX-501 dose 1, Rimiducid, BPX-501 dose 2 - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia
Phase 1 / Phase 2Active not recruitingBellicum Pharmaceuticals362013-03-012022-07-12

Conditions studied

Leukemia, Myeloid, Acute (5)  ·  Myelodysplastic Syndromes (5)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Anemia, Aplastic (3)  ·  Cytopenia (3)  ·  Hematologic Neoplasms (3)  ·  Leukemia (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Primary Immunodeficiency Diseases (3)  ·  Anemia (2)  ·  Anemia, Diamond-Blackfan (2)  ·  Anemia, Sickle Cell (2)  ·  Fanconi Anemia (2)  ·  Hemoglobinopathies (2)  ·  Osteopetrosis (2)

Sponsors

Bellicum Pharmaceuticals (5)

Countries

United States (3)  ·  Italy (2)  ·  United Kingdom (1)